Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$25.16 -0.13 (-0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcutis Biotherapeutics (ARQT) Price to Earnings (2026)

Updated

Arcutis Biotherapeutics' (ARQT) Price to Earnings came in at 115.47 for Q2 2026.

Analysis

Arcutis Biotherapeutics (ARQT) Price to Earnings (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Arcutis Biotherapeutics 3.16 Bn 2.44 Bn 118.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 115.47
API Access

Arcutis Biotherapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ARQT&period=max&api_key=YOUR_API_KEY